Mason, J. M., Logan, H. L., Budke, B., Wu, M., Pawlowski, M., Weichselbaum, R. R., . . . Connell, P. P. (2014). The RAD51-stimulatory compound RS-1 can exploit the RAD51 overexpression that exists in cancer cells and tumors.
Citação norma ChicagoMason, Jennifer M., Hillary L. Logan, Brian Budke, Megan Wu, Michal Pawlowski, Ralph R. Weichselbaum, Alan P. Kozikowski, Douglas K. Bishop, and Philip P. Connell. The RAD51-stimulatory Compound RS-1 Can Exploit the RAD51 Overexpression That Exists in Cancer Cells and Tumors. 2014.
MLA引文Mason, Jennifer M., et al. The RAD51-stimulatory Compound RS-1 Can Exploit the RAD51 Overexpression That Exists in Cancer Cells and Tumors. 2014.
警告:這些引文格式不一定是100%准確.